Discover
GKOS
Glaukos Corporation
137.57
200 x undefined
500 x undefined
bid
ask
-
2.19
1.57%
350 @ 04:54 AM
138.99 +1.42 (1.03%)
| Ytd | 21.84% | |
| 1y | 34.19% |
136.34
day range
141.36
73.16
52 week range
148.11
| Open | 139.06 | Prev Close | 139.76 | Low | 136.34 | High | 141.36 | Mkt Cap | 8.08B |
| Vol | 577.22K | Avg Vol | 976.39K | EPS | -3.30 | P/E | N/A | Forward P/E | 310.15 |
| Beta | 0.81 | Short Ratio | 3.15 | Inst. Own | 102.08% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-29 | 50-d Avg | 128.76 | 200-d Avg | 109.76 | 1yr Est | 157.50 |
GKOS News
benzinga.com
Piper Sandler Reiterates Overweight on Glaukos, Maintains $165 Price Target
Piper Sandler analyst Adam Maeder reiterates Glaukos (NYSE:GKOS) with a Overweight and maintains
benzinga.com
Glaukos Completes Patient Enrollment In Its Phase 2 Clinical Study Of GLK-321 For Demodex Blephariti
Glaukos Corporation (NYSE:GKOS), an ophthalmic pharmaceutical and medical technology company focused
businesswire.com
Glaukos Announces Completion of Patient Enrollment in Phase 2 Study of GLK-321 for Demodex Blepharit
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical
benzinga.com
Delta Air Lines To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed outlook on top names. Baird raised prices for Ryder System and J
benzinga.com
Needham Maintains Buy on Glaukos, Raises Price Target to $150
Needham analyst David Saxon maintains Glaukos (NYSE:GKOS) with a Buy and raises the price target
benzinga.com
Citigroup Maintains Buy on Glaukos, Raises Price Target to $162
Citigroup analyst Joanne Wuensch maintains Glaukos (NYSE:GKOS) with a Buy and raises the price ta